As the first frame-type myopia control product on the market that combines a dual mechanism (myopia defocus + higher-order aberration), Tian Tong - Haoyue Lens holds an invention patent certificate, enabling "one pair of glasses, two functions".

The combination of myopia defocus microlenses and free toric surface microcylinders not only ensures adaptability in the early stage but also provides variability of signals in the later stage. The density of the microstructure transitions from dense to sparse from the inside out, with a filling rate of 55%. Its unique dual-effect myopia control mechanism presents variable optical signals at the fundus, achieving excellent control results.

It covers a wide range of lens powers and can be made into positive-power lenses. This allows early myopia control intervention for patients with mild hyperopia or insufficient hyperopic reserve, delaying the onset of true myopia.

Six-month clinical data from Tianjin Eye Hospital shows that the average annual axial length growth with the advanced version is only 0.10mm. Compared with the control group using DIMS lenses, its effectiveness is improved by 54.5%.